Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors.
Borchmann S, Selenz C, Lohmann M, Ludwig H, Gassa A, Brägelmann J, Lohneis P, Meder L, Mattlener J, Breid S, Nill M, Fassunke J, Wisdom AJ, Compes A, Gathof B, Alakus H, Kirsch D, Hekmat K, Büttner R, Reinhardt HC, Hallek M, Ullrich RT.
Borchmann S, et al. Among authors: gassa a.
J Immunother Cancer. 2022 Oct;10(10):e004781. doi: 10.1136/jitc-2022-004781.
J Immunother Cancer. 2022.
PMID: 36223955
Free PMC article.